Filing Details

Accession Number:
0000921503-13-000100
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-09-19 16:35:07
Reporting Period:
2013-09-17
Filing Date:
2013-09-19
Accepted Time:
2013-09-19 16:35:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
921503 Blyth Inc BTH Pharmaceutical Preparations (2834) 362984916
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1382293 Andrew Todd Goergen
1 East Weaver Street
Greenwich CT 06831
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Acquisiton 2013-09-17 20,000 $12.34 60,830 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common 80,000 Indirect By TAGAPT, LLC
Common 263,184 Indirect By Trust MCT
Common 1,352,750 Indirect By Ropart Investments, LLC
Common 33,714 Indirect By Trust for Brother
Common 3,600 Indirect Spousal
Common 2,605 Indirect By Trust for Children
Common 33,714 Indirect By Trust
Common 101,146 Indirect By Trust for Children and Brother's Children
Footnotes
  1. Represents a weighted average purchase price for transactions reported on this date. The range of prices for transactions reported in this line is: $12.20 to $12.45. The reporting person undertakes to provide upon request by the Securites and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
  2. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.
  3. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.